TriMas Corporation (TRS)

Featured in Small-Cap Stocks

TriMas Corporation is a Nasdaq-listed common stock issuer with operations tied to consumer products, aerospace and defense, and industrial end markets. The company organizes its business into two segments: Packaging and Specialty Products. Its Packaging segment includes dispensing systems, closures, jar products, integrated dispensers, bag-in-box products, and related consumable components sold under brands such as Rieke, Taplast, Affaba & Ferrari, Aarts Packaging, Intertech, Omega Plastics, and Rapak. The Specialty Products segment focuses on steel cylinders used for transporting, storing, and dispensing packaged and compressed gases, marketed under the Norris Cylinder brand. TriMas sells through direct sales personnel, third-party agents, and distributors. Incorporated in 1986, the company is headquartered in Bloomfield Hills, Michigan.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-TRS
$45.63
13.5% Upside
Fair
$45
11.9% Upside
Fair
Good
0.16
0.4%
July 30, 2026
79.4x
1.0x
2.2x
1.465 B
622.6 M
23.7%
80.9%
2.9
0.7%
348.8%
Valuation • Fair Value

TriMas Corporation (NASDAQ-TRS) Fair Value by Valuation Model

Compare the primary fair value estimate for TriMas Corporation (NASDAQ-TRS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$45.63

Estimated upside of 13.5% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$54.73

Discounted cash flow valuation reference.

Ben Graham Formula Value

$5.63

Classic Ben Graham valuation formula reference.

DDM Fair Value

$34.52

Dividend discount model valuation reference.

EPV Fair Value

$39.97

Earnings power value estimate.

Comps Fair Value

$39.33

Comparable-company valuation reference.

Analyst Price Target

$45

Analysts imply upside of 11.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for TriMas Corporation (NASDAQ-TRS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for TriMas Corporation (NASDAQ-TRS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

661.5 M

Current operating scale indicator.

Revenue Forecast

448.3 M

Forward revenue estimate.

EBITDA

60.98 M

Current operating profitability reference.

EBITDA Forecast

98.891 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review TriMas Corporation (NASDAQ-TRS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for TriMas Corporation (NASDAQ-TRS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-3.02

No elevated caution signal from this screen.

Altman Z-Score

2.9

Intermediate risk zone.

FCF / Net Income

348.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for TriMas Corporation (NASDAQ-TRS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for TriMas Corporation (NASDAQ-TRS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 30, 2026

Days to Earnings

9

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.4%

Income yield reference.

Upcoming Dividend

0.16

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

0.7%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for TriMas Corporation (NASDAQ-TRS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

TriMas Corporation (NASDAQ-TRS) Stock Forecast & Technical Outlook

Review TriMas Corporation (NASDAQ-TRS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for TriMas Corporation (NASDAQ-TRS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for TriMas Corporation (NASDAQ-TRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for TriMas Corporation (NASDAQ-TRS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for TriMas Corporation (NASDAQ-TRS) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for TriMas Corporation (NASDAQ-TRS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for TriMas Corporation (NASDAQ-TRS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, TriMas Corporation (NASDAQ-TRS) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

TriMas Corporation (NASDAQ-TRS) Stock FAQ

Quick answers about TriMas Corporation (NASDAQ-TRS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$45.63
Estimated upside 13.5%
Valuation Rating
Undervalued
Estimated upside of 13.5%
Analyst Target
$45
Implied upside 11.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for TriMas Corporation (NASDAQ-TRS) is $45.63. This implies an estimated upside of 13.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 13.5% versus the current market price.

The available analyst price target for TriMas Corporation (NASDAQ-TRS) is $45. The analyst target implies estimated upside of 11.9%.

The current financial health read for TriMas Corporation (NASDAQ-TRS) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for TriMas Corporation (NASDAQ-TRS) is July 30, 2026.

Based on the current data, dividend yield is 0.4%, upcoming dividend amount is 0.16.

The current P/E ratio listed for TriMas Corporation (NASDAQ-TRS) is 79.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for TriMas Corporation is 1.465 B.

The current enterprise value listed for TriMas Corporation is 622.6 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for TriMas Corporation is NASDAQ-TRS, and the stock is listed on NASDAQ.

TriMas Corporation (NASDAQ-TRS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for TriMas Corporation is 23.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for TriMas Corporation is 80.9%. Free float helps investors understand how much of the share base is available for public trading.